| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |